First two cases of primary carcinoma of the vagina successfully treated with concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high‐dose‐rate interstitial brachytherapy: A case report and published work review

@article{Mabuchi2015FirstTC,
  title={First two cases of primary carcinoma of the vagina successfully treated with concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high‐dose‐rate interstitial brachytherapy: A case report and published work review},
  author={Seiji Mabuchi and Mahiru Kawano and Fumiaki Isohashi and Hiromasa Kuroda and Tomoyuki Sasano and Tadashi Kimura},
  journal={Journal of Obstetrics and Gynaecology Research},
  year={2015},
  volume={41}
}
Vaginal carcinoma is rare, accounting for only 2% of all gynecological malignancies. Due to a lack of prospective randomized studies, the role of concurrent chemoradiotherapy in the treatment of primary vaginal carcinoma remains unclear. We report the first two cases of primary vaginal carcinoma successfully treated with a regimen involving concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high‐dose‐rate interstitial brachytherapy. These cases strongly indicate that… 

References

SHOWING 1-10 OF 15 REFERENCES
Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review
TLDR
CCRT is effective for primary squamous cell carcinoma of the vagina and should be considered for treatment in patients with high-risk disease having good performance status, as evaluated by the Radiation Therapy Oncology Group (RTOG) scoring system.
Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report
TLDR
A case of a 52-year-old woman with clear cell adenocarcinoma of the rectovaginal septum presenting with vaginal hemorrhage is reported and management with concurrent chemoradiation with cisplatin and paclitaxel is discussed.
Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum.
A Phase I Study of Concurrent Weekly Carboplatin and Paclitaxel Combined With Intensity-Modulated Pelvic Radiotherapy as an Adjuvant Treatment for Early-Stage Cervical Cancer Patients With Positive Pelvic Lymph Nodes
Objectives The objective of this study was to determine the maximum tolerated dose (MTD) and acute dose-limiting toxicities (DLTs) of intravenous carboplatin plus paclitaxel combined with
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
TLDR
Regimens of radiotherapy and chemotherapy that contain cisplatin improve the rates of survival and progression-free survival among women with locally advanced cervical cancer.
Primary Vaginal Cancer and Chemoradiotherapy: A Patterns-of-Care Analysis
TLDR
Chemoradiotherapy utilization for VC has increased since 1999, but it is failed to delineate a CSS or OS benefit for CRT in this cohort.
Chemoradiation for primary invasive squamous carcinoma of the vagina
  • J. Dalrymple, A. Russell, L. Smith
  • Medicine
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • 2004
TLDR
Radiation with synchronous chemotherapy is an effective treatment for squamous carcinoma of the vagina treated with chemoradiation and cancer control outcomes compare favorably with previously published results employing higher dose radiation as monotherapy.
Definitive irradiation in carcinoma of the vagina: long-term evaluation of results.
Concurrent Chemoradiation for Vaginal Cancer
TLDR
Vaginal cancer results in poor outcomes and adequate radiation dose is essential to ensure curative management, and concurrent chemotherapy should be considered for vaginal cancer patients.
Definitive radiation therapy for squamous cell carcinoma of the vagina.
...
1
2
...